Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated November 4, 2024, please note that the audio recording of the earnings call on the Unaudited Financial Results for the second quarter and half year ended September 30, 2024, held on November 11, 2024 at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings

pdf

Aurobindo Pharma Ltd.

16 Aug 2024

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Submission of Transcript of Earning call on unaudited financial results of Q1 2024-25.

pdf

Aurobindo Pharma Ltd.

12 Aug 2024

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 5, 2024, please note that the audio recording of the earnings call on the Unaudited Financial Results for the first quarter ended June 30, 2024, held on August 12, 2024, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings

pdf

Aurobindo Pharma Ltd.

31 May 2024

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Submission of transcript of earnings call held on May 27, 2024 on audited financial results for the fourth quarter and year ended on March 31, 2024.

pdf

Aurobindo Pharma Ltd.

27 May 2024

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Submission of Audio recording of earnings call held on 27th May 2024 on Audited Financial Results for the year ended 31st March 2024.

pdf

Aurobindo Pharma Ltd.

16 Feb 2024

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Submission of Earnings Call Transcript on Q3 FY2023-24

pdf

Aurobindo Pharma Ltd.

12 Feb 2024

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of Earnings Call held on 12th February 2024 on Q3FY24 Unaudited Financial Results

pdf

Aurobindo Pharma Ltd.

15 Nov 2023

1082.45

2.31%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q2FY24 Earnings Call held on November 10, 2023

pdf

Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts